)
Edge11 Sep 2026
Texas Pacific Land Corporation: Keeper of the Permian Basin
Land once granted to a failed 19th-century railroad now generates royalties for Texas Pacific Land Corporation across the Permian Basin.
Atrys Health
Atrys Health (ATRY) investor relations material
Atrys Health Q2 2026 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Q2 2026 earnings summary10 Sep, 2026
Executive summary
Revenue grew 9.4% year-over-year in H1 2026 to €77.7M, with Q2 growth accelerating to 12.3%.
EBITDA increased 21.3% to €9.3M, with margin improvement to 11.9% and adjusted EBITDA growth exceeding 44% excluding accounting effects.
Strong regional performance: Latin America up 26.1% (Mexico +151.1%), Portugal up 6.7%, Spain up 1.3%.
Sale of Prevention Division/ASPY in January 2026 for €145M enabled a €141M net debt reduction and transformational deleveraging.
New organizational model by geography implemented in 2026, driving Opex efficiencies and profitability.
Financial highlights
Gross margin rose 6.6% to €32.7M, though margin on revenue declined to 42.0% from 43.1% due to business mix.
Operating cash flow surged 191.5% to €7.2M, driven by EBITDA growth and lower CAPEX.
Net financial debt dropped 79.2% to €35.4M as of June 2026 after ASPY sale.
Financial expenses fell 43.3% year-over-year, with €4.4M in savings due to deleveraging.
Consolidated net loss narrowed to €6.4M from €9.4M in 1H 2025.
Outlook and guidance
2026 guidance maintained: revenue €156.5M (+11%), EBITDA €20.5M (+40%), operating cash flow €13.5M (+125%).
Ongoing debt reorganization to align with the 2026-2028 Strategic Plan.
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Latest events from Atrys Health
- Q1 2026 saw 6.3% revenue growth, 15.4% EBITDA rise, and an 81.1% debt reduction.ATRY
Q1 2026 - Revenue up 8.5%, net debt slashed, Oncology drives growth, and strong 2026 outlook.ATRYQ4 2025
- 8.2% revenue growth driven by Oncology and Diagnostics; ASPY divestment to cut debt and refocus.ATRYQ3 2025
- Revenue up 7.8% to €115.8M, net loss narrows, but margin and financial pressures persist.ATRYQ2 2025
- Adjusted EBITDA up 31.7% and revenues up 7.2%, led by strong LATAM and Oncology growth.ATRYQ3 2024
- Q1 2025 revenue up 11.2% and new CEO named to support continued growth and expansion.ATRYQ1 2025
- Revenue and EBITDA grew, losses narrowed, but cash reserves declined sharply.ATRYQ4 2024
Next Atrys Health earnings date
Q3 202613 Nov, 2026
Atrys Health
Next Atrys Health earnings date
Q3 202613 Nov, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
Explore our global coverage